Zabrina Lockett

459 total citations
5 papers, 335 citations indexed

About

Zabrina Lockett is a scholar working on Clinical Biochemistry, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Zabrina Lockett has authored 5 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Biochemistry, 3 papers in Pharmacology and 3 papers in Applied Microbiology and Biotechnology. Recurrent topics in Zabrina Lockett's work include Bacterial Identification and Susceptibility Testing (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Use and Resistance (3 papers). Zabrina Lockett is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Use and Resistance (3 papers). Zabrina Lockett collaborates with scholars based in United States. Zabrina Lockett's co-authors include Sanchita Basu Das, Angella Charnot‐Katsikas, Patricia J. Simner, William B. Brasso, Stephen G. Jenkins, Virginia Pierce, April M. Bobenchik, J. Kristie Johnson, Brandi Limbago and David Lonsway and has published in prestigious journals such as Journal of Clinical Microbiology and Open Forum Infectious Diseases.

In The Last Decade

Zabrina Lockett

4 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zabrina Lockett United States 2 317 162 160 81 53 5 335
Garance Cotellon France 8 264 0.8× 127 0.8× 86 0.5× 57 0.7× 36 0.7× 11 282
William B. Brasso United States 6 358 1.1× 178 1.1× 192 1.2× 91 1.1× 60 1.1× 8 410
K. Wilkinson United Kingdom 6 322 1.0× 166 1.0× 182 1.1× 57 0.7× 52 1.0× 7 401
Diana Doyle Ireland 4 289 0.9× 169 1.0× 102 0.6× 46 0.6× 31 0.6× 6 320
Blanca Pérez-Viso Spain 12 224 0.7× 81 0.5× 112 0.7× 60 0.7× 54 1.0× 21 293
Belita N. A. Opene United States 10 272 0.9× 124 0.8× 172 1.1× 63 0.8× 32 0.6× 12 358
Warda Bouchahrouf Belgium 7 288 0.9× 172 1.1× 69 0.4× 48 0.6× 26 0.5× 8 305
Trevor Winstanley United Kingdom 4 245 0.8× 99 0.6× 130 0.8× 55 0.7× 67 1.3× 4 348
Kateřina Chudějová Czechia 12 383 1.2× 203 1.3× 76 0.5× 52 0.6× 36 0.7× 18 425
Ana Paula Cury Brazil 10 249 0.8× 92 0.6× 58 0.4× 82 1.0× 75 1.4× 17 293

Countries citing papers authored by Zabrina Lockett

Since Specialization
Citations

This map shows the geographic impact of Zabrina Lockett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zabrina Lockett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zabrina Lockett more than expected).

Fields of papers citing papers by Zabrina Lockett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zabrina Lockett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zabrina Lockett. The network helps show where Zabrina Lockett may publish in the future.

Co-authorship network of co-authors of Zabrina Lockett

This figure shows the co-authorship network connecting the top 25 collaborators of Zabrina Lockett. A scholar is included among the top collaborators of Zabrina Lockett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zabrina Lockett. Zabrina Lockett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Garner, Omai B., Maria M. Traczewski, Denise Beasley, et al.. (2020). 667. Multicenter Assessment of Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using Updated CLSI Levofloxacin Breakpoints on MicroScan Dried Gram Negative MIC Panels. Open Forum Infectious Diseases. 7(Supplement_1). S388–S389. 1 indexed citations
2.
Traczewski, Maria M., Denise Beasley, Amanda Harrington, et al.. (2020). 673. Updated CLSI Ciprofloxacin Breakpoints from a Multicenter Assessment for Enterobacterales, Salmonella spp. and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels. Open Forum Infectious Diseases. 7(Supplement_1). S391–S391. 1 indexed citations
3.
Garner, Omai B., Maria M. Traczewski, Denise Beasley, et al.. (2019). 2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels. Open Forum Infectious Diseases. 6(Supplement_2). S722–S722.
4.
Simner, Patricia J., J. Kristie Johnson, William B. Brasso, et al.. (2017). Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii. Journal of Clinical Microbiology. 56(1). 48 indexed citations
5.
Pierce, Virginia, Patricia J. Simner, David Lonsway, et al.. (2017). Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae. Journal of Clinical Microbiology. 55(8). 2321–2333. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026